Brief: Adocia reports topline results of Biochaperone Glucagon Phase 1 study
Nov 20 (Reuters) - ADOCIA SA ADOC.PA :
* ADOCIA REPORTS TOPLINE RESULTS OF BIOCHAPERONE GLUCAGON
PHASE 1
STUDY
* BIOCHAPERONE GLUCAGON WAS FOUND TO BE SAFE AND WELL
TOLERATED
IN PEOPLE WITH TYPE 1 DIABETES
* BIOCHAPERONE GLUCAGON DEMONSTRATED EFFICACY IN RESCUING
PARTICIPANTS FROM MEDICALLY INDUCED HYPOGLYCEMIA IN MEDIAN TIME
OF 11 MINS
Source text for Eikon: ID:nBw2gYx2Ra
Further company coverage: ADOC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Adocia SA
See all newsBrief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro